Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025CONTINUUM Lifelong Learning in Neurology

Inclusion Body Myositis

View Full Paper
Ask AI
Bookmark
Share

Authors

ENElie Naddaf

Discussion

Loading...

Member takes

Overview

This article reveals the diagnostic criteria and challenges in clinical trials for inclusion body myositis, highlighting treatment complexities.

Key Points

  • Diagnosis relies on muscle biopsy and cytosolic nucleotidase 1A antibodies.
  • Recent diagnostic criteria introduced by the European Neuromuscular Centre improve accuracy in diagnosis.
  • The limited clinical trial landscape poses challenges for effective treatment development in inclusion body myositis.
  • A multidisciplinary approach is essential in managing the complexities of aging-related disorders linked to IBM.

Cite This Study

Elie Naddaf (2025) studied this question.

synapsesocial.com/papers/68e02f3cf0e39f13e7fa2683https://doi.org/10.1212/cont.0000000000001616
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Inclusion Body Myositis2024 · 5 citations
  2. 2Two emerging phenotypes of atypical inclusion body myositis: illustrative cases2023 · 10 citations
  3. 3Paradigm shift in the pathomechanisms and treatment of inclusion body myositis: at the crossroads of cell-autonomous muscle degeneration and immune activation2026
  4. 4Inclusion body myositis: new insights into pathogenesis and therapeutic perspectives2026
  5. 5Inclusion body myositis: an underdiagnosed myopathy of older people2005 · 19 citations